About RNTech
Founded in France (2002), RNTECH is an international biotech company dedicated to the early diagnosis and treatment of digestive tract's cancers.
With facilities in France, Romania (2003), the company discovers, validates and develops up to the market place products and services currently focusing on colorectal and pancreatic cancer for its internal project but covering the entire digestive tract for collaborative and contract research projects.
The 2 subsidiaries of the company pursue distinctive objectives.
* RNTECH SAS, France, is the mother company and specializes, on discovery, validation and development of:
o novel drugable targets and screening tools.
o new biomarkers for diagnostics and monitoring tools development up to the market place.
* RNTECH Romania Srl, Romania, designed to remain a wholly owned subsidiary, is operating, in collaboration with the Clinical Institute Fundeni (Bucharest) a specialised biobank collecting tissue and body fluids samples from patients treated for digestive tract cancers and attached clinical data representing at the end of 2006, 1500 patients.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of RNTech
News about RNTech
Here you will find RNTech SAS
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
